Sclareol is a potent enhancer of doxorubicin: Evaluation of the free combination and co-loaded nanostructured lipid carriers against breast cancer

Elsevier, Life Sciences, (232), p. 116678, 2019

Journal article published in 2019 by Gabriel Silva Marques Borges, Juliana de Oliveira Silva, Renata Salgado Fernandes, Ângelo Malachias de Souza, Geovanni Dantas Cassali, Maria Irene Yoshida, Elaine Amaral Leite, André Luis Branco de Barros

This paper was not found in any repository, but could be made available legally by the author.

Full text: Unavailable

Preprint: archiving allowed

Upload

Postprint: archiving restricted

Upload

Published version: archiving forbidden

Policy details

Data provided by